Analysis of human kallikrein 7 expression as a potential biomarker in cervical neoplasia

International Journal of Cancer

Volumn 127, Issue 2, 2010, Pages 485-490

  Termini, Lara ^a   Maciag, Paulo Cesar ^b   Soares, Fernando Augusto ^c   Nonogaki, Suely ^d   Pereira, Sônia Maria Miranda ^d   Alves, Venâncio Avancini Ferreira ^e   Longatto Filho, Adhemar ^d,f   Villa, Luisa Lina ^a  

^a HOSPITAL ALEMÃO OSWALDO CRUZ   (Brazil)

^b ADVAXIS INC   (United States)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d INSTITUTO ADOLFO LUTZ   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF MINHO   (Portugal)

Author keywords

Biomarker; Cervical neoplasia; Human kallikrein 7; Human papillomavirus; Tissue microarray

Indexed keywords

BIOLOGICAL MARKER; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; KALLIKREIN; KLK7 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; DISEASE SEVERITY; EPITHELIUM CELL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; UTERINE CERVICITIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; ADENOCARCINOMA; CANCER STAGING; ENZYME IMMUNOASSAY; METABOLISM; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KALLIKREINS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 77953716477     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25046     Document Type: Article

References (45)

1. Castellsagué X, de Sanjosé S, Aguado T, Louie KS, Bruni L, Muñoz J, Diaz M, Irwin K, Gacic M, Beauvais O, Albero G, Ferrer E, et al. HPV and cervical cancer in the world. 2007 Report. Vaccine 2007;25:3.
2. WHO/Information Centre on Human Papilloma Virus (HPV) and Cervical Cancer, 2009. http://www.who.int/hpvcentre.
3. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996;1288:55-78.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19. (Pubitemid 29406813)
5. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65. (Pubitemid 34293391)
6. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989;261:737-43.
7. Sasieni PD, Cuzick J, Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 1996;73:1001-5.
8. Duarte-Franco E, Franco EL. Cancer of the uterine cervix. BMC Womens Health 2004;4:13.
9. Termini L, Boccardo E, Esteves GH, Hirata R, Jr, Martins WK, Colo AE, Neves EJ, Villa LL, Reis LF. Characterization of global transcription profile of normal and HPV-immortalized keratinocytes and their response to TNF treatment. BMC Med Genomics 2008;1:29.
10. Borgoño CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2004;2:257-80.
11. Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem 2002;48:1198-205.
12. Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 2001;2:184-204.
13. Hansson L, Strömqvist M, Bäckman A, Wallbrandt P, Carlstein A, Egelrud T. Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J Biol Chem 1994;269:19420-6. (Pubitemid 24978758)
14. Lundström A, Egelrud T. Stratum corneum chymotryptic enzyme: a proteinase which may be generally present in the stratum corneum and with a possible involvement in desquamation. Acta Derm Venereol 1991;71:471-4.
15. Lundström A, Egelrud T. Evidence that cell shedding from plantar stratum corneum in vitro involves endogenous proteolysis of the desmosomal protein desmoglein I. J Invest Dermatol 1990;94:216-20. (Pubitemid 20059165)
16. Suzuki Y, Koyama J, Moro O, Horii I, Kikuchi K, Tanida M, Tagami H. The role of two endogenous proteases of the stratum corneum in degradation of desmoglein-1 and their reduced activity in the skin of ichthyotic patients. Br J Dermatol 1996;134:460-4. (Pubitemid 26092118)
17. Caubet C, Jonca N, Brattsand M, Guerrin M, Bernard D, Schmidt R, Egelrud T, Simon M, Serre G. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family. SCTE/KLK5/h. K5 and. SCCE/KLK7/h. K7. J Invest Dermatol 2004;122:1235-44. (Pubitemid 38651099)
18. Descargues P, Deraison C, Prost C, Fraitag S, Mazereeuw-Hautier J, D'Alessio M, Ishida-Yamamoto A, Bodemer C, Zambruno G, Hovnanian A. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin-and chymotrypsin-like hyperactivity in Netherton syndrome. J Invest Dermatol 2006;126:1622-32. (Pubitemid 43910379)
19. Ramani VC, Hennings L, Haun RS. Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer. BMC Cancer 2008;8:373.
20. Talieri M, Diamandis EP, Gourgiotis D, Mathioudaki K, Scorilas A. Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. Thromb Haemost 2004;91:180-6. (Pubitemid 38111235)
21. Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin Cancer Res 2003;9:1710-20. (Pubitemid 36554595)
22. Kyriakopoulou LG, Yousef GM, Scorilas A, Katsaros D, Massobrio M, Fracchioli S, Diamandis EP. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer. Clin Biochem 2003;36:135-43. (Pubitemid 36287493)
23. Tian X, Shigemasa K, Hirata E, Gu L, Uebaba Y, Nagai N, O'Brien TJ, Ohama K. Expression of human kallikrein 7 (hK7/SCCE) and its inhibitor antileukoprotease (ALP/SLPI) in uterine endocervical glands and in cervical adenocarcinomas. Oncol Rep 2004;5:1001-6.
24. Santin AD, Cane' S, Bellone S, Bignotti E, Palmieri M, De Las Casas LE, Roman JJ, Anfossi S, O'Brien T, Pecorelli S. The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells. Gynecol Oncol 2004;94:283-8.
25. IARC-International Agency for Research on Cancer-World Health Organization. IARC Monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses, vol. 90. Lyon: IARC Press, 2007. Available at: http://www-dep.iarc.fr/.
26. Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003;95:1336-43.
27. Perona JJ, Craik CS. Structural basis of substrate specificity in the serine proteases. Protein Sci 1995;4:337-60.
28. Noël A, Gilles C, Bajou K, Devy L, Kebers F, Lewalle JM, Maquoi E, Munaut C, Remacle A, Foidart JM. Emerging roles for proteinases in cancer. Invasion Metastasis 1997;17:221-39.
29. Turgeon VL, Houenou LJ. The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system. Brain Res Brain Res Rev 1997;25:85-95.
30. Sim RB, Laich A. Serine proteases of the complement system. Biochem Soc Trans 2000;28:545-50.
31. Del Rosso M, Fibbi G, Pucci M, D'Alessio S, Del Rosso A, Magnelli L, Chiarugi V. Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin Exp Metastasis 2002;19:193-207.
32. Ekholm E, Egelrud T. Stratum corneum chymotryptic enzyme in psoriasis. Arch Dermatol Res 1999;291:195-200. (Pubitemid 29191826)
33. Sondell B, Dyberg P, Anneroth GK, Ostman PO, Egelrud T. Association between expression of stratum corneum chymotryptic enzyme and pathological keratinization in human oral mucosa. Acta Derm Venereol 1996;76:177-81. (Pubitemid 26186294)
34. Nylander-Lundqvist E, Back O, Egelrud T. IL-1beta activation in human epidermis. J Immunol 1996;157:1699-704.
35. Nylander-Lundqvist E, Egelrud T. Formation of active IL-1b from pro-IL-1 b catalyzed by stratum corneum chymotryptic enzyme in vitro. Acta Derm Venereol 1997;77:203-6. (Pubitemid 27240189)
36. Diamandis EP, Yousef GM. Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Exp Mol Diagn 2001;1:182-90.
37. Yousef GM, Diamandis EP. Expanded human tissue kallikrein family-a novel panel of cancer biomarkers. Tumour Biol 2002;23:185-92.
38. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
39. Zielinski GD, Snijders PJ, Rozendaal L, Daalmeijer NF, Risse EK, Voorhorst FJ, Jiwa NM, van der Linden HC, de Schipper FA, Runsink AP, Meijer CJ. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. J Pathol 2003;201:535-43.
40. Ekholm IE, Brattsand M, Egelrud T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process?J Invest Dermatol 2000;114:56-63.
41. Borgoño CA, Michael IP, Komatsu N, Jayakumar A, Kapadia R, Clayman GL, Sotiropoulou G, Diamandis EP. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 2007;282:3640-52.
42. Petraki CD, Karavana VN, Skoufogiannis PT, Little SP, Howarth DJ, Yousef GM, Diamandis EP. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. J Histochem Cytochem 2001;49:1431-41.
43. Petraki CD, Karavana VN, Luo LY, Diamandis EP. Human kallikrein 10 expression in normal tissues by immunohistochemistry. J Histochem Cytochem 2002;50:1247-61.
44. Petraki CD, Karavana VN, Diamandis EP. Human kallikrein 13 expression in normal tissues: an immunohistochemical study. J Histochem Cytochem 2003;51:493-501.
45. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-19.